J. Quesada

发表

Alpha interferon for induction of remission in hairy-cell leukemia.

J. Manning, J. Reuben, E. Hersh, 1984, The New England journal of medicine.

Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients.

J. Quesada, J. Gutterman, 1983, Journal of the National Cancer Institute.

Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.

T. Merigan, S. Horning, E. Borden, 1984, The American journal of medicine.

Morphoproteomic study of primary pleural angiosarcoma of lymphangioendothelial lineage: a case report.

Robert E. Brown, E. Ferguson, J. Quesada, 2013, Annals of clinical and laboratory science.

Liver regeneration following repeat SBRT.

J. Quesada, B. Teh, A. Farach, 2015, Journal of gastrointestinal oncology.

Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients

W. A. Bradley, R. Kurzrock, J. Quesada, 1986, The Journal of experimental medicine.

Treatment of multiple myeloma with recombinant alpha-interferon.

B. Barlogie, E. Borden, J. Quesada, 1986, Blood.

Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant 7-lnterferon in Cancer Patients1

R. Kurzrock, J. Quesada, J. Gutterman, 2006 .

Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon.

E. Kleinerman, I. Fidler, R. Kurzrock, 1986, Cancer research.

Immune Thrombocytopenia Following α-Interferon Therapy in Patients With Cancer

B. Barlogie, P. Mclaughlin, J. Quesada, 1985 .

PSORIASIS AND ALPHA-INTERFERON

J. Quesada, J. Gutterman, 1986, The Lancet.

Treatment of multiple myeloma with recombinant alpha-interferon.

B. Barlogie, E. Borden, J. Quesada, 1986, Blood.

Growth factor-mediated tumor cell proliferation in hairy cell leukemia

J. Quesada, R. Montagna, A. Maizel, 1985, The Journal of experimental medicine.

Antibody‐dependent cell‐mediated cytotoxicity in human cancer: Characterization of patient leukocyte activity and treatment effects

E. Hersh, J. Quesada, J. Gutterman, 1982, Cancer.

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

J. Quesada, J. Gutterman, D. Swanson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Production of B cell growth factor(s) by neoplastic B cells from hairy cell leukemia patients.

J. Quesada, C. Sahasrabuddhe, R. Ford, 1986, Blood.

Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2011, Virus research.

Autologous mixed lymphocyte reaction in lymphoid malignancies. Lack of correlation with disease activity or clinical remission

J. Reuben, J. Quesada, S. Murphy, 1982, Cancer Immunology, Immunotherapy.

Role of interferons in the therapy of metastatic renal cell carcinoma.

J. Quesada, 1989, Urology.

Treatment of hairy cell leukemia with recombinant alpha-interferon.

J. Manning, E. Hersh, J. Quesada, 1986, Blood.

Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.

J. Quesada, J. Gutterman, D. Swanson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Multiple Myeloma With Recombinant a-Interferon

B. Barlogie, E. Borden, J. Quesada, 2005 .

Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

T. Merigan, S. Horning, J. Quesada, 1982, Annals of internal medicine.

Hairy cell leukemia: clinical effects of the methanol extraction residue (MER) of BCG, lithium carbonate and mononuclear cell-enriched leukocyte transfusions.

A. Zander, E. Hersh, J. Quesada, 1981, Leukemia research.

Renal cell carcinoma: antitumor effects of leukocyte interferon.

J. Quesada, J. Gutterman, D. Swanson, 1983, Cancer research.

Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer.

E. Hersh, J. Quesada, J. Gutterman, 1982, Journal of interferon research.

ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS

J. Quesada, J. Gutterman, A. Palleroni, 1983, The Lancet.

Clinical toxicity of interferons in cancer patients: a review.

R. Kurzrock, J. Quesada, J. Gutterman, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer.

J. Quesada, J. Gutterman, J. U. Gutterman, 1981, Texas reports on biology and medicine.

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.

J. Quesada, J. Gutterman, F. Adams, 1984, JAMA.

The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy

J. Quesada, R. Amato, 2012, Sarcoma.

Treatment of hairy cell leukemia with recombinant α-interferon

J. Manning, J. Reuben, E. Hersh, 1986 .

Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patients.

E. Hersh, J. Quesada, J. Gutterman, 1981, Journal of the National Cancer Institute.

Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant γ-lnterferon in Cancer Patients

R. Kurzrock, J. Quesada, J. Gutterman, 1985 .

Interferons in cancer research: An update

J. Quesada, 1983 .

Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.

R. Kurzrock, J. Reuben, E. Hersh, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durable complete remissions after 2′‐deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha

J. Quesada, M. Blick, J. Lepe-Zúñiga, 1990, American journal of hematology.

Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.

E. Hersh, J. Quesada, J. Gutterman, 1983, Journal of the National Cancer Institute.

Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.

R. Kurzrock, J. Quesada, J. Gutterman, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia

B. Barlogie, R. Kurzrock, J. Quesada, 1988, American journal of hematology.

Sarcoidosis presenting as metastatic lymphadenopathy in breast cancer.

J. Quesada, B. Teh, M. Schwartz, 2014, Clinical breast cancer.

ALPHA INTERFERONS IN B‐CELL NEOPLASMS

J. Quesada, J. Gutterman, 1986, British journal of haematology.

Alpha interferons in the treatment of hairy cell leukemia.

J. Quesada, 1986, Immunobiology.

Evaluation of therapy with methanol extraction residue of BCG (MER)

E. Hersh, J. Quesada, J. Gutterman, 1982, Cancer Immunology, Immunotherapy.

Pharmacokinetic study of partially pure gamma-interferon in cancer patients.

J. Quesada, J. Gutterman, M. Rosenblum, 1984, Cancer research.

Interferons in the treatment of human neoplasms.

J. Quesada, J. Gutterman, 1987, Journal of interferon research.

Host defence factors and prognosis in hairy cell leukemia.

E. Hersh, J. Quesada, M. Keating, 1982, Leukemia research.

Case of polycythemia vera concurrent with FIP1L1-PDGFRA-positive myeloproliferative neoplasm with eosinophilia.

J. Quesada, N. Nguyen, Brandy Shattuck, 2012, Cancer Genetics.

HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2009, Vaccine.

Interferons and cell growth regulation.

J. Quesada, J. Gutterman, 1984, European Journal of Cancer and Clinical Oncology.

Prognostic factors in hairy cell leukemia. (Leukemic reticuloendotheliosis)

E. Hersh, J. Quesada, E. Freireich, 1984, Cancer.

Biologic response modifiers in the therapy of metastatic renal cell carcinoma.

J. Quesada, 1988, Seminars in oncology.

Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.

R. Kurzrock, J. Quesada, S. Sherwin, 1987, Journal of biological response modifiers.

Interferons in the Treatment of Metastatic Renal Cell Carcinoma (RCC)

J. Quesada, 1988 .

A phase I study of recombinant DNA produced leukocyte interferon by an intermittent schedule

J. Quesada, J. Gutterman, S. Fein, 1982 .

Guidelines for the treatment of hairy cell leukemia.

D. Catovsky, J. Quesada, H. Golomb, 1987, Leukemia.

Serologic studies in hairy cell leukemia: high prevalence of Epstein-Barr and cytomegalovirus antibodies and absence of human T-cell lymphotrophic viruses antibodies.

E. Hersh, J. Quesada, J. Reuben, 1986, Leukemia research.

Biologic therapy of hairy cell leukemia.

E. Hersh, J. Quesada, J. Gutterman, 1984, Seminars in oncology.

Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette‐guerin

E. Hersh, J. Quesada, J. Gutterman, 1980, Cancer.

Immune thrombocytopenia following alpha-interferon therapy in patients with cancer.

J U Gutterman, B. Barlogie, P. Mclaughlin, 1985, JAMA.

Phase I study of i.v. administered recombinant gamma interferon in cancer patients.

R. Kurzrock, J. Quesada, M. Rosenblum, 1986, Cancer treatment reports.

Bone involvement in hairy cell leukemia.

H. Libshitz, J. Quesada, M. Keating, 1983, The American journal of medicine.

Treatment of hairy cell leukemia with alpha interferons

E. Hersh, J. Quesada, J. Gutterman, 1986, Cancer.

Acute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma.

J. Quesada, N. Nguyen, Laura Kidd, 2013, Annals of clinical and laboratory science.

Efficacy of Alpha Interferons in Hairy Cell Leukemia (HCL) and Status of the Interferon System of Patients in Remission

J. Quesada, J. Gutterman, J. Lepe-Zúñiga, 1987 .

Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

R. Kurzrock, J. Quesada, J. Gutterman, 1985, Cancer research.

Cross-reactive red blood cell antigen-related substances in human leukocyte alpha interferon.

J. Quesada, B. Lichtiger, K. S. Hui, 1986, Archives of pathology & laboratory medicine.

Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.

J. Quesada, J. Gutterman, L. Evans, 1988, Journal of biological response modifiers.

Antitumor effects of partially pure human leukocyte interferon in renal cell carcinoma

J. Quesada, J. Gutterman, D. Swanson, 1982 .

The Role of Interferon Alpha in the Treatment of Hairy Cell Leukemia (HCL)

J. Quesada, 1988 .

Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.

J. Quesada, J. Gutterman, J. Lepe-Zúñiga, 1987, Leukemia.

Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.

S. Baron, J. Quesada, J. Reuben, 1987, Hematologic pathology.

Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.

H. Kantarjian, R. Benjamin, J. Quesada, 1986, European journal of cancer & clinical oncology.